Public Company News

iHuman Inc. Announces First Quarter 2021 Unaudited Financial Results

BEIJING, June 8, 2021 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("Human" or the "Company"), a leading childhood edutainment company inChina, today announced its unaudited financial results for the first quarter ended March 31, 2021. First Quarter 2021 Highlights * Total revenues were RMB226.7...

2021-06-08 13:47 17020

Ying Hai Announces Possible Acquisition of a Zhuhai Travel Company

HONG KONG, June 8, 2021 /PRNewswire/ -- Ying Hai Group Holdings Company Limited ("the Company" or "Ying Hai Group", together with its subsidiaries, the "Group", HKSE stock code: 8668) is pleased to announce that, the Group will acquire Zhuhai Huanya International Tourism Co., Ltd. ("Target Comp...

2021-06-08 11:35 15867

A Snapshot of SID Display Week 2021: BOE leads the way in display industry, bringing momentum to "China's moment"

BEIJING, June 7, 2021 /PRNewswire/ -- The below news release is from DINGKEJI.COM about BOE Technology Group: In order to move forward, you have to leave where you are now -- this is an inspirational quote from bestsellerUnder the Tuscan Sun. With the rapid advancement of display technology, t...

2021-06-08 11:17 7045

Pearl Abyss Releases BUGATTI Collaboration for Black Desert

SEOUL, South Korea, June 8, 2021 /PRNewswire/ -- Pearl Abyss today announced a collaboration with BUGATTI. The prestigious French brand will appear across the world ofBlack Desert across all platforms. Adventurers can now enjoy this collaboration through special quests and branded items.   

2021-06-08 10:47 3187

Innovent Biologics and IASO Biotherapeutics to Present Updated Data from its Anti-BCMA CAR-T Therapy in Relapsed/Refractory Multiple Myeloma at European Hematology Association (EHA) Congress

SAN FRANCISCO and SUZHOU, China, June 8, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2021-06-08 08:00 5545

Live from ASCO 2021 | Ascentage Pharma Delivers Oral Presentation Featuring Updated Data Demonstrating Promising Efficacy and Safety of Bcl-2 Inhibitor Lisaftoclax (APG-2575) in Patients with Relapsed or Refractory CLL/SLL

SUZHOU, China, and ROCKVILLE, MD, June 8, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today released updated results from the first...

2021-06-08 07:30 5520

Live from ASCO 2021 | Ascentage Pharma Presents Updated Results of MDM2-p53 Inhibitor Alrizomadlin (APG-115) Demonstrating an ORR of 24.1% Including Complete Response in Combination with Pembrolizumab in Patients with Advanced Melanoma Resistant or Refractory to Prior Immuno-Oncologic Drugs

SUZHOU, China, and ROCKVILLE, Md., June 8, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today presented in an oral presentation at t...

2021-06-08 07:21 12875

TIAN RUIXIANG Holdings Ltd Announces Initial Closing of Follow-on Public Offering

BEIJING, June 07, 2021 /PRNewswire/ -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the "Company"), aChina-based insurance broker, announced today the initial closing of its previously announced best-effort follow-on public offering for the sale of up to 4,800,000 units offered by the Company at a ...

2021-06-08 04:30 13964

Senmiao Technology Announces Over 2.1 Million Completed Rides on its Ride-Hailing Platform in May 2021

CHENGDU, China, June 7, 2021 /PRNewswire/ -- Senmiao Technology Limited ("Senmiao") (Nasdaq: AIHS), a financing and servicing company focused on the online ride-hailing industry inChina as well as an operator of its own online ride-hailing platform, today announced operating metrics for its propr...

2021-06-07 21:00 6376

ORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available in the United States and Puerto Rico

RARITAN, N.J., June 7, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO OPTIX™ Reader, which allows lower-volume transfusion labs to elevate their standard of patient care ...

2021-06-07 21:00 6518

Elekta's new strategy to focus on growth and access to radiation therapy

STOCKHOLM, June 7, 2021 /PRNewswire/ -- At Elekta's (EKTA-B.ST) Capital Markets Day, CEO,Gustaf Salford, and members from his executive management team introduced the company's mid-term strategy, called Access 2025. The strategy reflects the work the company will continue to do to pursue the visi...

2021-06-07 20:44 14189

Huya Inc. Joins the Coalition to End Wildlife Trafficking Online, Leveraging Power of Livestreaming for Public Welfare

GUANGZHOU, China, June 7, 2021 /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading Chinese livestreaming platform, has joined the Coalition to End Wildlife Trafficking Online (the "Coalition") for World Environment Day which fell onJune 5. It hopes to clean up further th...

2021-06-07 20:31 7797

Ambow Education Inks Strategic Cooperation Agreement with Kylinsoft

BEIJING, June 7, 2021 /PRNewswire/ -- Ambow Education Holding Ltd. ("Ambow" or "the Company") (NYSE American: AMBO),China's leading provider of educational and career enhancement services, today announced it has entered into a cooperation agreement ("Cooperation Agreement") with Kylinsoft, a lead...

2021-06-07 20:30 6495

Study of Paxalisib in Primary CNS Lymphoma at Dana-Farber Cancer Institute Enrols First Patient

SYDNEY, June 7, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that a phase II study of Kazia's investigational new drug, paxalisib, in primary CNS lymphoma has been initiated at Dana-Farber Cancer Ins...

2021-06-07 20:00 7238

RedHill Biopharma Completes Enrollment of Oral Opaganib Phase 2/3 COVID-19 Study

The global Phase 2/3 study of orally-administered opaganib for the treatment of severe COVID-19 enrolled a total of 475 patients, more than the planned 464 Opaganib is uniquely positioned as a leading novel, dual-action, investigational COVID-19 oral pill Blinded blended mortality rates encourag...

2021-06-07 19:00 5415

Tantech Announces Closing of US$7.0 Million Offering

LISHUI, China, June 7, 2021 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company"), a clean energy company inChina, today announced that it closed a previously announced private placement transaction (the "Private Placement"), raising approximatelyUS$7.0 million in gross...

2021-06-07 19:00 7476

Clarivate Forecasts Nearly 70% of North American, European and Asia Pacific Adult Populations Will Be Vaccinated for COVID-19 by September 2021

New report analyzes how the emergence and increased availability of vaccines will impact the recovery of healthcare markets across the globe LONDON, June 7, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of inn...

2021-06-07 16:15 6673

Elekta and Philips deepen strategic partnership in precise and individualized oncology care

STOCKHOLM and AMSTERDAM, June 7, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) and Royal Philips (NYSE: PHG, AEX: PHIA) today signed agreements to deepen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology solutions. The extended collab...

2021-06-07 16:02 6722

WeChat Pay HK and Visa Collaborate to Support Disbursement of Hong Kong SAR Government's Consumption Voucher Scheme

* Collaboration aims to boost economic recovery and digital transformation of small and medium-sized businesses inHong Kong * WeChat Pay HK to waive service fee transactions for "WeChat Pay HK Checkout" merchants during the scheme period; Visa to invest in driving consumptionvoucher usage HON...

2021-06-07 15:30 17026

Aker Solutions Extends Relationship with Cognizant to Modernize its IT Systems and Help Speed Transition to Renewable Energy

By transforming and modernizing its IT Systems, Aker Solutions can offer more flexibility and faster time-to-market for its oil and gas customers TEANECK, N.J., June 7, 2021 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) announced today that it has extended its relationship with global engineering com...

2021-06-07 15:30 9070